BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1473041)

  • 1. Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
    Whiteside C; Templeton DM
    Can J Physiol Pharmacol; 1992 Aug; 70(8):1096-103. PubMed ID: 1473041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.
    Jyothirmayi GN; Reddi AS
    Hypertension; 1993 Jun; 21(6 Pt 1):795-802. PubMed ID: 8500860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular proteoglycans in diabetes. Partial structural characterization and metabolism of de novo synthesized heparan-35SO4 and dermatan-35SO4 proteoglycans in streptozocin-induced diabetic rats.
    Klein DJ; Brown DM; Oegema TR
    Diabetes; 1986 Oct; 35(10):1130-42. PubMed ID: 2944782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of glomerular heparan-35SO4 proteoglycan by heparin from glomeruli of streptozocin-induced diabetic rats.
    Klein DJ; Oegema TR; Brown DM
    Diabetes; 1989 Jan; 38(1):130-9. PubMed ID: 2521210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
    Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention of glomerular basement membrane-proteoglycans accompanying loss of anionic site staining in experimental diabetes.
    Templeton DM
    Lab Invest; 1989 Aug; 61(2):202-11. PubMed ID: 2755078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats.
    Reddi AS; Ramamurthi R; Miller M; Dhuper S; Lasker N
    Biochem Med Metab Biol; 1991 Feb; 45(1):119-31. PubMed ID: 2015105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of galactose regimen on glomerular heparan sulfate synthesis and albumin excretion in diabetic rats.
    Jaya B; Hu L; Bauman JW; Fu SC; Reddi AS
    Res Commun Chem Pathol Pharmacol; 1993 May; 80(2):143-52. PubMed ID: 8321919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
    Whiteside CI; Thompson J
    Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of glomerular anionic sites and the development of albuminuria in rats with streptozotocin-induced diabetes.
    Moriya T; Nakazawa K; Itoh N; Shigematsu H; Okada N; Aizawa T; Yamada T; Yajima Y
    Nephron; 1993; 65(3):444-8. PubMed ID: 8289997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(35)S]sulfate incorporation into glomerular basement membrane glycosaminoglycans is decreased in experimental diabetes.
    Cohen MP; Surma ML
    J Lab Clin Med; 1981 Nov; 98(5):715-22. PubMed ID: 7028893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of albuminuria by captopril in diabetic rats.
    Reddi AS
    Gen Pharmacol; 1991; 22(2):323-8. PubMed ID: 2055428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence.
    Kanwar YS; Rosenzweig LJ; Linker A; Jakubowski ML
    Proc Natl Acad Sci U S A; 1983 Apr; 80(8):2272-5. PubMed ID: 6572976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glomerular proteoglycan metabolism in experimental non-insulin dependent diabetes mellitus.
    Fioretto P; Keane WF; Kasiske BL; O'Donnell MP; Klein DJ
    J Am Soc Nephrol; 1993 Apr; 3(10):1694-704. PubMed ID: 8318686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced glomerular angiotensin II receptor density in diabetes mellitus in the rat: time course and mechanism.
    Wilkes BM
    Endocrinology; 1987 Apr; 120(4):1291-8. PubMed ID: 3549258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
    Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
    Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    Singh R; Singh AK; Leehey DJ
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparan sulfate analysis from diabetic rat glomeruli.
    Lauer ME; Hascall VC; Wang A
    J Biol Chem; 2007 Jan; 282(2):843-52. PubMed ID: 17038308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.
    Schambelan M; Blake S; Sraer J; Bens M; Nivez MP; Wahbe F
    J Clin Invest; 1985 Feb; 75(2):404-12. PubMed ID: 3156147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.
    van den Born J; Pisa B; Bakker MA; Celie JW; Straatman C; Thomas S; Viberti GC; Kjellen L; Berden JH
    J Biol Chem; 2006 Oct; 281(40):29606-13. PubMed ID: 16885165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.